Proteomic responses in the human dopaminergic LUHMES cell line to imidacloprid and its metabolites imidacloprid-olefin and desnitro-imidacloprid.


Journal

Pesticide biochemistry and physiology
ISSN: 1095-9939
Titre abrégé: Pestic Biochem Physiol
Pays: United States
ID NLM: 1301573

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 27 03 2023
revised: 08 05 2023
accepted: 18 05 2023
medline: 4 8 2023
pubmed: 3 8 2023
entrez: 2 8 2023
Statut: ppublish

Résumé

Neonicotinoids (neonics) are amongst the most commonly used class of pesticides globally. In the United States, imidacloprid (IMI) is extensively used for agriculture and in other common applications such as house-hold pest control. Regular exposure to IMI, and several of its known metabolites including IMI-olefin and desnitro-imidacloprid (DN-IMI), has been shown to be harmful to many organisms including mammals, birds, and fish. Studies show that neonics bind human nicotinicacetylcholine receptors (nAChRs) and cause cellular toxicity. In the dopaminergic Lund human mesencephalic (LUHMES) cell line, IMI and other neonics (10-100 μM) have been recently shown to activate intracellular calcium signaling through nAChRs. Thus, we examined proteomic responses of LUHMES cells to a 48-h treatment with 50 μM IMI, IMI-olefin, or DN-IMI. Our findings show differential effects of these neonics on cellular protein expression. Bioinformatic analysis of significantly altered proteins indicates an effect of IMI, IMI-olefin, and DN-IMI on protein synthesis and ribosomal function. These findings suggest a role for protein synthesis and transcriptional regulation in neonic-mediated dopaminergic neurotoxicity.

Identifiants

pubmed: 37532312
pii: S0048-3575(23)00138-4
doi: 10.1016/j.pestbp.2023.105473
pii:
doi:

Substances chimiques

imidacloprid 3BN7M937V8
Insecticides 0
Alkenes 0
Neonicotinoids 0
Nitro Compounds 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105473

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Patricia Sinclair (P)

Interdisciplinary Program in Neuroscience, George Mason University.

Julia Hakeem (J)

Interdisciplinary Program in Neuroscience, George Mason University.

Sreehari G Kumar (SG)

Interdisciplinary Program in Neuroscience, George Mason University.

Dominik Loser (D)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770, Reutlingen, Germany.

Kushan Dixit (K)

Interdisciplinary Program in Neuroscience, George Mason University.

Marcel Leist (M)

In Vitro Toxicology and Biomedicine, Department Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Universitaetsstr. 10, 78457 Constance, Germany.

Udo Kraushaar (U)

NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770, Reutlingen, Germany.

Nadine Kabbani (N)

Interdisciplinary Program in Neuroscience, George Mason University; School of Systems Biology, George Mason University. Electronic address: nkabbani@gmu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH